Did Biden Bet the Future of America on the "Lithium Triangle"?
FREE investor's report details the plan to cut more ties with China and how it could create the next boom for early investors. But you must act fast.
Discover the one company set to break China's grip

AVTE Insider Trading

Insider Ownership Percentage: 17.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,090,776.95

Aerovate Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aerovate Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aerovate Therapeutics Share Price & Price History

Current Price: $16.49
Price Change: Price Decrease of -0.19 (-1.14%)
As of 10/5/2022 01:00 AM ET

This chart shows the closing price history over time for AVTE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Did Biden Bet the Future of America on the "Lithium Triangle"?
FREE investor's report details the plan to cut more ties with China and how it could create the next boom for early investors. But you must act fast.
Discover the one company set to break China's grip

Aerovate Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2022Benjamin T. DakeinsiderSell7,520$17.33$130,321.60View SEC Filing Icon  
9/8/2022Benjamin T. DakeinsiderSell3,120$18.20$56,784.00View SEC Filing Icon  
9/6/2022Benjamin T. DakeinsiderSell9,166$18.53$169,845.98View SEC Filing Icon  
8/18/2022Ralph NivenInsiderSell2,250$21.18$47,655.001,609View SEC Filing Icon  
8/16/2022Benjamin T. DakeinsiderSell21,000$23.00$483,000.00View SEC Filing Icon  
8/11/2022Benjamin T. DakeinsiderSell1,347$23.93$32,233.71View SEC Filing Icon  
8/8/2022Benjamin T. DakeinsiderSell6,943$24.62$170,936.66View SEC Filing Icon  
See Full Table
Did Biden Bet the Future of America on the "Lithium Triangle"?
FREE investor's report details the plan to cut more ties with China and how it could create the next boom for early investors. But you must act fast.
Discover the one company set to break China's grip

SEC Filings (Institutional Ownership Changes) for Aerovate Therapeutics (NASDAQ:AVTE)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AVTE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aerovate Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/16/2022Jane Street Group LLC11,717$0.18M0.0%N/A0.048%Search for SEC Filing on Google Icon
8/16/2022Parkwood LLC32,414$32K0.1%N/A0.133%Search for SEC Filing on Google Icon
8/15/2022State Street Corp178,554$2.79M0.0%+6.3%0.731%Search for SEC Filing on Google Icon
8/15/2022Citadel Advisors LLC1,592,009$24.88M0.0%-0.1%6.522%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC24,066$0.38M0.0%N/A0.099%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.4,297$67K0.0%-33.8%0.018%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp76,140$1.19M0.0%-27.1%0.312%Search for SEC Filing on Google Icon
8/12/2022FMR LLC634,766$9.92M0.0%-11.8%2.600%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers13,193$0.21M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.5,876$92K0.0%-34.8%0.024%Search for SEC Filing on Google Icon
8/4/2022Chicago Partners Investment Group LLC10,163$0.23M0.0%N/A0.042%Search for SEC Filing on Google Icon
8/3/2022Atlas Venture Life Science Advisors LLC2,638,297$41.24M6.9%-15.0%10.808%Search for SEC Filing on Google Icon
7/29/2022Russell Investments Group Ltd.2,056$32K0.0%N/A0.008%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank1,462$27K0.0%N/A0.006%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE4,103$75K0.0%-56.9%0.017%Search for SEC Filing on Google Icon
5/18/2022Golden State Equity Partners20,980$0.39M0.2%+31.7%0.086%Search for SEC Filing on Google Icon
5/16/2022State Street Corp168,037$3.08M0.0%+9.0%0.688%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp104,450$1.92M0.0%+19.8%0.428%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.32,853$0.60M0.0%+32.8%0.135%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.6,494$0.12M0.0%+21.3%0.027%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.480,110$8.80M0.0%+2.5%1.967%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.746,934$13.69M0.0%+2.3%3.060%Search for SEC Filing on Google Icon
5/12/2022Penn Mutual Asset Management LLC17,458$0.32M0.4%N/A0.072%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.1,420$26K0.0%-59.1%0.006%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp30,487$0.56M0.0%+28.0%0.125%Search for SEC Filing on Google Icon
5/11/2022Skandinaviska Enskilda Banken AB publ14,108$0.26M0.0%N/A0.058%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.9,007$0.17M0.0%+49.8%0.037%Search for SEC Filing on Google Icon
5/10/2022Sectoral Asset Management Inc.218,913$4.01M0.7%-22.6%0.897%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund12,591$0.23M0.0%+164.0%0.052%Search for SEC Filing on Google Icon
2/18/2022TCG Crossover Management LLC853,330$10.06M4.7%N/A3.496%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC1,597,479$18.84M0.0%+0.2%6.544%Search for SEC Filing on Google Icon
2/11/2022Parkwood LLC37,156$0.44M0.1%-22.7%0.152%Search for SEC Filing on Google Icon
2/3/2022OUP Management Co. LLC603,762$7.12M3.2%N/A2.473%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund4,770$56K0.0%+165.0%0.020%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC1,594,813$32.41M0.0%-1.2%6.533%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.53,872$1.13M0.0%N/A0.221%Search for SEC Filing on Google Icon
11/15/2021Sectoral Asset Management Inc341,367$7.16M0.6%-31.7%1.398%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC114,423$2.40M0.0%N/A0.469%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.483,018$10.13M0.0%N/A1.979%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG5,794$0.12M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund1,800$38K0.0%N/A0.007%Search for SEC Filing on Google Icon
10/22/2021Strs Ohio2,300$48K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC65,043$1.49M0.0%N/A0.281%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC1,614,998$35.47M0.0%N/A6.989%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC9,000$0.21M0.0%N/A0.039%Search for SEC Filing on Google Icon
8/16/2021RA Capital Management L.P.8,263,982$188.67M3.0%N/A35.762%Search for SEC Filing on Google Icon
8/16/2021Maven Securities LTD9,854$0.23M0.0%N/A0.043%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.104,755$2.39M0.0%N/A0.453%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aerovate Therapeutics logo
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Read More on Aerovate Therapeutics

Today's Range

Now: $16.49
Low: $15.56
High: $16.83

50 Day Range

MA: $19.73
Low: $14.77
High: $25.79

52 Week Range

Now: $16.49
Low: $7.74
High: $27.83

Volume

34,119 shs

Average Volume

75,359 shs

Market Capitalization

$402.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.46

Who are the company insiders with the largest holdings of Aerovate Therapeutics?

Aerovate Therapeutics' top insider shareholders include:
  1. Ralph Niven (Insider)
  2. Benjamin T Dake (Insider)
  3. Cormorant Asset Management, Lp (Insider)
Learn More about top insider investors at Aerovate Therapeutics.
Did Biden Bet the Future of America on the "Lithium Triangle"?
FREE investor's report details the plan to cut more ties with China and how it could create the next boom for early investors. But you must act fast.
Discover the one company set to break China's grip